{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:58:56Z","timestamp":1792087136086,"version":"4.4.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-020-00544-y","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T11:10:51Z","timestamp":1609931451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Skin Penetration Enhancement Strategies Used in the Development of Melanoma Topical Treatments"],"prefix":"10.1208","volume":"23","author":[{"given":"Supreeda","family":"Tambunlertchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-6633","authenticated-orcid":false,"given":"Aliasger K.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"7","key":"544_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc.2017.43","volume":"17","author":"R Ossio","year":"2017","unstructured":"Ossio R, Rold\u00e1n-Mar\u00edn R, Mart\u00ednez-Said H, Adams DJ, Robles-Espinoza CD. Melanoma: a global perspective. Nat Rev Cancer. 2017;17(7):393\u20134.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"544_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"544_CR3","first-page":"228","volume":"6","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sheikh MS. Melanoma: molecular pathogenesis and therapeutic management. Mol Cell Pharmacol. 2014;6(3):228.","journal-title":"Mol Cell Pharmacol"},{"issue":"1","key":"544_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mrfmmm.2004.11.016","volume":"571","author":"N Agar","year":"2005","unstructured":"Agar N, Young AR. Melanogenesis: a photoprotective response to DNA damage? Mutat Res Fund Mol Mech Mutagenesis. 2005;571(1):121\u201332.","journal-title":"Mutat Res Fund Mol Mech Mutagenesis"},{"issue":"4","key":"544_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3322\/canjclin.50.4.215","volume":"50","author":"DS Rigel","year":"2000","unstructured":"Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin. 2000;50(4):215\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"544_CR6","first-page":"978","volume":"51","author":"JJ Escobar-Ch\u00e1vez","year":"2012","unstructured":"Escobar-Ch\u00e1vez JJ, Rodr\u00edguez-Cruz IM, Dom\u00ednguez-Delgado CL, D\u00edaz-Torres R, Revilla-V\u00e1zquez AL, Al\u00e9ncaster NC. Nanocarrier systems for transdermal drug delivery. Recent Adv Novel Drug Carr Syst. 2012;51(8):978\u201353.","journal-title":"Recent Adv Novel Drug Carr Syst"},{"issue":"4","key":"544_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11095-012-0946-7","volume":"30","author":"SN Andrews","year":"2013","unstructured":"Andrews SN, Jeong E, Prausnitz MR. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res. 2013;30(4):1099\u2013109.","journal-title":"Pharm Res"},{"issue":"5","key":"544_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1586\/14760584.6.5.835","volume":"6","author":"MA Tomai","year":"2007","unstructured":"Tomai MA, Miller RL, Lipson KE, Kieper WC, Zarraga IE, Vasilakos JP. Resiquimod and other immune response modifiers as vaccine adjuvants. Expert Rev Vaccines. 2007;6(5):835\u201347.","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"544_CR9","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-06-027599","volume":"108","author":"E Kamphuis","year":"2006","unstructured":"Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006;108(10):3253\u201361.","journal-title":"Blood."},{"issue":"7","key":"544_CR10","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/blood-2005-01-0342","volume":"106","author":"M Gunzer","year":"2005","unstructured":"Gunzer M, Riemann H, Basoglu Y, Hillmer A, Weishaupt C, Balkow S, et al. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. Blood. 2005;106(7):2424\u201332.","journal-title":"Blood."},{"key":"544_CR11","doi-asserted-by":"crossref","unstructured":"Wille-Reece U, Wu CYy, Flynn BJ, Kedl RM, Seder RA. Immunization with HIV-1 Gag protein conjugated to a TLR7\/8 agonist results in the generation of HIV-1 gag-specific Th1 and CD8+ T cell responses. J Immunol 2005;174(12):7676\u20137683.","DOI":"10.4049\/jimmunol.174.12.7676"},{"issue":"12","key":"544_CR12","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/AAC.47.12.3846-3852.2003","volume":"47","author":"DN Sauder","year":"2003","unstructured":"Sauder DN, Smith MH, Senta-McMillian T, Soria I, Meng T-C. Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults. Antimicrob Agents Chemother. 2003;47(12):3846\u201352.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"544_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/jid.1965.140","volume":"45","author":"RJ Scheuplein","year":"1965","unstructured":"Scheuplein RJ. Mechanism of percutaneous adsorption: I. routes of penetration and the influence of solubility. J Investig Dermatol. 1965;45(5):334\u201346.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"544_CR14","first-page":"702","volume":"51","author":"RJ Scheuplein","year":"1971","unstructured":"Scheuplein RJ, Blank IH. Permeability of the skin. Phys Rev. 1971;51(4):702\u201347.","journal-title":"Phys Rev"},{"issue":"4","key":"544_CR15","first-page":"433","volume":"33","author":"K Gross","year":"2007","unstructured":"Gross K, Kircik L, Kricorian G. 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg. 2007;33(4):433\u201340.","journal-title":"Dermatol Surg"},{"issue":"8","key":"544_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1468-3083.2012.04619.x","volume":"27","author":"R Cosgarea","year":"2013","unstructured":"Cosgarea R, Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27(8):980\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"544_CR17","first-page":"205","volume":"9","author":"MS Bettencourt","year":"2016","unstructured":"Bettencourt MS. Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%. Clinical, cosmetic and investigational. Dermatology. 2016;9:205.","journal-title":"Dermatology."},{"issue":"1","key":"544_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.apsb.2013.12.013","volume":"4","author":"YW Naguib","year":"2014","unstructured":"Naguib YW, Kumar A, Cui Z. The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil. Acta Pharm Sin B. 2014;4(1):94\u20139.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"544_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1081\/DDC-100100984","volume":"26","author":"VR Sinha","year":"2000","unstructured":"Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm. 2000;26(11):1131\u201340.","journal-title":"Drug Dev Ind Pharm"},{"key":"544_CR20","unstructured":"Taveira SF, Lopez RV. Topical administration of anticancer drugs for skin cancer treatment. Topical Administration of anticancer drugs for skin cancer treatment 2011:247\u2013272."},{"issue":"1\u20132","key":"544_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","volume":"447","author":"ME Lane","year":"2013","unstructured":"Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1\u20132):12\u201321.","journal-title":"Int J Pharm"},{"issue":"4","key":"544_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jphp.12334","volume":"67","author":"A Herman","year":"2015","unstructured":"Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67(4):473\u201385.","journal-title":"J Pharm Pharmacol"},{"key":"544_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","volume":"64","author":"AC Williams","year":"2012","unstructured":"Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128\u201337.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"544_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.15171\/apb.2018.021","volume":"8","author":"T Haque","year":"2018","unstructured":"Haque T, Talukder MMU. Chemical enhancer: a simplistic way to modulate barrier function of the stratum corneum. Adv Pharm Bull. 2018;8(2):169\u201379.","journal-title":"Adv Pharm Bull"},{"issue":"8","key":"544_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/02652048.2019.1677796","volume":"36","author":"A Sharma","year":"2019","unstructured":"Sharma A, Sharma D, Baldi A, Jyoti K, Chandra R, Madan J. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour. J Microencapsul. 2019;36(8):759\u201374.","journal-title":"J Microencapsul"},{"issue":"6","key":"544_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1211\/jpp.59.6.0005","volume":"59","author":"P Suppasansatorn","year":"2007","unstructured":"Suppasansatorn P, Nimmannit U, Conway BR, Du L, Wang Y. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). J Pharm Pharmacol. 2007;59(6):787\u201394.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"544_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijpharm.2005.04.004","volume":"298","author":"BN Singh","year":"2005","unstructured":"Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm. 2005;298(1):98\u2013107.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"544_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2006.08.021","volume":"329","author":"H Herai","year":"2007","unstructured":"Herai H, Gratieri T, Thomazine JA, Bentley MVLB, Lopez RFV. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. Int J Pharm. 2007;329(1\u20132):88\u201393.","journal-title":"Int J Pharm"},{"issue":"9","key":"544_CR29","doi-asserted-by":"publisher","first-page":"8956","DOI":"10.1021\/acsnano.6b04989","volume":"10","author":"Y Ye","year":"2016","unstructured":"Ye Y, Wang J, Hu Q, Hochu GM, Xin H, Wang C, et al. Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors. ACS Nano. 2016;10(9):8956\u201363.","journal-title":"ACS Nano"},{"issue":"4","key":"544_CR30","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","volume":"16","author":"C Wang","year":"2016","unstructured":"Wang C, Ye Y, Hochu GM, Sadeghifar H, Gu Z. Enhanced Cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 2016;16(4):2334\u201340.","journal-title":"Nano Lett"},{"issue":"3","key":"544_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41591-020-0787-6","volume":"26","author":"AR Tadros","year":"2020","unstructured":"Tadros AR, Romanyuk A, Miller IC, Santiago A, Noel RK, O\u2019Farrell L, et al. STAR particles for enhanced topical drug and vaccine delivery. Nat Med. 2020;26(3):341\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"544_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2008.11.002","volume":"134","author":"SF Taveira","year":"2009","unstructured":"Taveira SF, Nomizo A, Lopez RF. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J Control Release. 2009;134(1):35\u201340.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"544_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2007.11.037","volume":"353","author":"D Paolino","year":"2008","unstructured":"Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008;353(1\u20132):233\u201342.","journal-title":"Int J Pharm"},{"issue":"5","key":"544_CR34","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.3390\/molecules17055972","volume":"17","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012;17(5):5972\u201387.","journal-title":"Molecules."},{"issue":"10","key":"544_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/jphp.12772","volume":"69","author":"JH Ven\u00e2ncio","year":"2017","unstructured":"Ven\u00e2ncio JH, Andrade LM, Esteves NLS, Brito LB, Valadares MC, Oliveira GAR, et al. Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers. J Pharm Pharmacol. 2017;69(10):1318\u201326.","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"544_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1021\/mp8000556","volume":"5","author":"J-B Tagne","year":"2008","unstructured":"Tagne J-B, Kakumanu S, Nicolosi RJ. Nanoemulsion preparations of the anticancer drug Dacarbazine significantly increase its efficacy in a Xenograft mouse melanoma model. Mol Pharm. 2008;5(6):1055\u201363.","journal-title":"Mol Pharm"},{"issue":"2","key":"544_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12032-009-9192-1","volume":"27","author":"Q-H Zhao","year":"2010","unstructured":"Zhao Q-H, Zhang Y, Liu Y, Wang H-L, Shen Y-Y, Yang W-J, et al. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery. Med Oncol. 2010;27(2):203\u201312.","journal-title":"Med Oncol"},{"key":"544_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biopha.2015.05.002","volume":"73","author":"X Yu","year":"2015","unstructured":"Yu X, Du L, Li Y, Fu G, Jin Y. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother. 2015;73:6\u201311.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"544_CR39","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","volume":"12","author":"T Jiang","year":"2018","unstructured":"Jiang T, Wang T, Li T, Ma Y, Shen S, He B, et al. Enhanced transdermal drug delivery by Transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS Nano. 2018;12(10):9693\u2013701.","journal-title":"ACS Nano"},{"key":"544_CR40","first-page":"175","volume":"59","author":"J Hadgraft","year":"1993","unstructured":"Hadgraft J, Williams DG, Allan G. Azone. Mechanisms of action and clinical effect. Drugs Pharm Sci. 1993;59:175\u201397.","journal-title":"Drugs Pharm Sci"},{"issue":"2","key":"544_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.colsurfb.2008.05.001","volume":"65","author":"NA Charoo","year":"2008","unstructured":"Charoo NA, Shamsher AAA, Kohli K, Pillai K, Rahman Z. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloids Surf B: Biointerfaces. 2008;65(2):300\u20137.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"1\u20132","key":"544_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0378-5173(91)90341-K","volume":"76","author":"A Hoogstraate","year":"1991","unstructured":"Hoogstraate A, Verhoef J, Brussee J, Ijzerman A, Spies F, Bodde H. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int J Pharm. 1991;76(1\u20132):37\u201347.","journal-title":"Int J Pharm"},{"issue":"4","key":"544_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.2042-7158.1995.tb05795.x","volume":"47","author":"CS Leopold","year":"1995","unstructured":"Leopold CS, Lippold BC. An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC). J Pharm Pharmacol. 1995;47(4):276\u201381.","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"544_CR44","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1002\/bip.1977.360161017","volume":"16","author":"RP Oertel","year":"1977","unstructured":"Oertel RP. Protein conformational changes induced in human stratum corneum by organic sulfoxides: an infrared spectroscopic investigation. Biopolymers. 1977;16(10):2329\u201345.","journal-title":"Biopolymers"},{"issue":"2","key":"544_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0378-5173(95)00141-5","volume":"125","author":"AN Anigbogu","year":"1995","unstructured":"Anigbogu AN, Williams AC, Barry BW, Edwards HG. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm. 1995;125(2):265\u201382.","journal-title":"Int J Pharm"},{"issue":"1","key":"544_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0168-3659(87)90066-6","volume":"6","author":"BW Barry","year":"1987","unstructured":"Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85\u201397.","journal-title":"J Control Release"},{"issue":"5237","key":"544_CR47","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/2251052a0","volume":"225","author":"LA Goldsmith","year":"1970","unstructured":"Goldsmith LA, Baden HP. Uniquely oriented epidermal lipid. Nature. 1970;225(5237):1052\u20133.","journal-title":"Nature."},{"issue":"2","key":"544_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0168-3659(98)00187-4","volume":"59","author":"TM Suhonen","year":"1999","unstructured":"Suhonen TM, Bouwstra JA, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. 1999;59(2):149\u201361.","journal-title":"J Control Release"},{"issue":"1","key":"544_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/jps.2600810112","volume":"81","author":"K Sugibayashi","year":"1992","unstructured":"Sugibayashi K, Nakayama S, Seki T, Hosoya KI, Morimoto YJ. Mechanism of skin penetration-enhancing effect by laurocapram. J Pharm Sci. 1992;81(1):58\u201364.","journal-title":"J Pharm Sci"},{"issue":"1","key":"544_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejpb.2009.04.016","volume":"73","author":"LD Simonetti","year":"2009","unstructured":"Simonetti LD, Gelfuso GM, Barbosa JC, Lopez RF. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. Eur J Pharm Biopharm. 2009;73(1):90\u20134.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"544_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF00252956","volume":"20","author":"MJ Soble","year":"1987","unstructured":"Soble MJ, Dorr RT, Plezia P, Breckenridge S. Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics. Cancer Chemother Pharmacol. 1987;20(1):33\u20136.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"544_CR52","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jama.1965.03090100042010","volume":"193","author":"AM Kligman","year":"1965","unstructured":"Kligman AM. Topical pharmacology and toxicology of dimethyl sulfoxide\u2014part 1. Jama. 1965;193(10):796\u2013804.","journal-title":"Jama."},{"issue":"11","key":"544_CR53","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/j.jid.2018.04.037","volume":"138","author":"A Nawaz","year":"2018","unstructured":"Nawaz A, Wong TW. Chitosan-carboxymethyl-5-fluorouracil-folate conjugate particles: microwave modulated uptake by skin and melanoma cells. J Investig Dermatol. 2018;138(11):2412\u201322.","journal-title":"J Investig Dermatol"},{"key":"544_CR54","doi-asserted-by":"crossref","unstructured":"Singh TRR, McMillan H, Mooney K, Alkilani AZ, Donnelly RF. 6 - Microneedles for drug delivery and monitoring. In: Li X, Zhou Y, editors. Microfluidic Devices for Biomedical Applications: Woodhead Publishing; 2013. p. 185\u2013230.","DOI":"10.1533\/9780857097040.2.185"},{"issue":"2","key":"544_CR55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejpb.2010.07.001","volume":"76","author":"J-H Park","year":"2010","unstructured":"Park J-H, Choi S-O, Seo S, Choy YB, Prausnitz MR. A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm. 2010;76(2):282\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"544_CR56","first-page":"1253","volume":"6","author":"A Kumar","year":"2011","unstructured":"Kumar A, Li X, Sandoval MA, Rodriguez BL, Sloat BR, Cui Z. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomedicine. 2011;6:1253.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"544_CR57","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.tiv.2010.08.012","volume":"24","author":"YA Gomaa","year":"2010","unstructured":"Gomaa YA, Morrow DIJ, Garland MJ, Donnelly RF, El-Khordagui LK, Meidan VM. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol in Vitro. 2010;24(7):1971\u20138.","journal-title":"Toxicol in Vitro"},{"issue":"2","key":"544_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jconrel.2012.08.011","volume":"163","author":"A Kumar","year":"2012","unstructured":"Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release. 2012;163(2):230\u20139.","journal-title":"J Control Release"},{"issue":"2","key":"544_CR59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2012.08.015","volume":"163","author":"NK Brogden","year":"2012","unstructured":"Brogden NK, Milewski M, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL. Diclofenac delays micropore closure following microneedle treatment in human subjects. J Control Release. 2012;163(2):220\u20139.","journal-title":"J Control Release"},{"issue":"3","key":"544_CR60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/lapl.200910134","volume":"7","author":"S Bal","year":"2010","unstructured":"Bal S, Kruithof A, Liebl H, Tomerius M, Bouwstra J, Lademann J, et al. In vivo visualization of microneedle conduits in human skin using laser scanning microscopy. Laser Phys Lett. 2010;7(3):242\u20136.","journal-title":"Laser Phys Lett"},{"issue":"4","key":"544_CR61","doi-asserted-by":"publisher","first-page":"046001","DOI":"10.1117\/1.3463002","volume":"15","author":"JG Enfield","year":"2010","unstructured":"Enfield JG, O'Connell M-L, Lawlor K, Jonathan E, O'Mahony C, Leahy MJ. In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J Biomed Opt. 2010;15(4):046001.","journal-title":"J Biomed Opt"},{"issue":"6","key":"544_CR62","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/pharmaceutics12060531","volume":"12","author":"Y-G Na","year":"2020","unstructured":"Na Y-G, Kim M, Han M, Huh HW, Kim J-S, Kim JC, et al. Characterization of hepatitis B surface antigen loaded Polylactic acid-based microneedle and its dermal safety profile. Pharmaceutics. 2020;12(6):531.","journal-title":"Pharmaceutics."},{"issue":"2","key":"544_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jocd.12426","volume":"17","author":"JY Hong","year":"2018","unstructured":"Hong JY, Ko EJ, Choi SY, Li K, Kim AR, Park JO, et al. Efficacy and safety of a novel, soluble microneedle patch for the improvement of facial wrinkle. J Cosmet Dermatol. 2018;17(2):235\u201341.","journal-title":"J Cosmet Dermatol"},{"key":"544_CR64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2014.04.045","volume":"193","author":"TW Wong","year":"2014","unstructured":"Wong TW. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery. J Control Release. 2014;193:257\u201369.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"544_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2010.09.008","volume":"401","author":"HR Moghimi","year":"2010","unstructured":"Moghimi HR, Alinaghi A, Erfan M. Investigating the potential of non-thermal microwave as a novel skin penetration enhancement method. Int J Pharm. 2010;401(1\u20132):47\u201350.","journal-title":"Int J Pharm"},{"issue":"1","key":"544_CR66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11095-012-0852-z","volume":"30","author":"TW Wong","year":"2013","unstructured":"Wong TW, Khaizan AN. Physicochemical modulation of skin barrier by microwave for transdermal drug delivery. Pharm Res. 2013;30(1):90\u2013103.","journal-title":"Pharm Res"},{"issue":"sup1","key":"544_CR67","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/21691401.2018.1431650","volume":"46","author":"NR Khan","year":"2018","unstructured":"Khan NR, Wong TW. 5-Fluorouracil ethosomes\u2013skin deposition and melanoma permeation synergism with microwave. Artif Cells Nanomed Biotechnol. 2018;46(sup1):568\u201377.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"6","key":"544_CR68","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/bem.2250130605","volume":"13","author":"C-K Chou","year":"1992","unstructured":"Chou C-K, Guy AW, Kunz LL, Johnson RB, Crowley JJ, Krupp JH. Long-term, low-level microwave irradiation of rats. Bioelectromagnetics. 1992;13(6):469\u201396.","journal-title":"Bioelectromagnetics."},{"issue":"Suppl. 1","key":"544_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000056388","volume":"14","author":"RH Guy","year":"2001","unstructured":"Guy RH, Delgado-Charro MB, Kalia YN. Iontophoretic transport across the skin. Skin Pharmacol Physiol. 2001;14(Suppl. 1):35\u201340.","journal-title":"Skin Pharmacol Physiol"},{"key":"544_CR70","doi-asserted-by":"crossref","unstructured":"Cullander C, Guy RH. Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J Investig Dermatol. 1991;97(1).","DOI":"10.1111\/1523-1747.ep12478060"},{"issue":"1","key":"544_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(98)00360-3","volume":"179","author":"AK Banga","year":"1999","unstructured":"Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999;179(1):1\u201319.","journal-title":"Int J Pharm"},{"issue":"12","key":"544_CR72","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1023\/A:1018909811672","volume":"10","author":"ER Scott","year":"1993","unstructured":"Scott ER, Laplaza AI, White HS, Phipps JB. Transport of ionic species in skin: contribution of pores to the overall skin conductance. Pharm Res. 1993;10(12):1699\u2013709.","journal-title":"Pharm Res"},{"key":"544_CR73","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/S0169-409X(02)00113-8","volume":"54","author":"B Barry","year":"2002","unstructured":"Barry B. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev. 2002;54:S31\u201340.","journal-title":"Adv Drug Deliv Rev"},{"key":"544_CR74","first-page":"121","volume-title":"Microneedle-iontophoresis combinations for enhanced transdermal drug delivery","author":"RF Donnelly","year":"2014","unstructured":"Donnelly RF, Garland MJ, Alkilani AZ. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery. Drug Delivery System: Springer; 2014. p. 121\u201332."},{"issue":"4","key":"544_CR75","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/pharmaceutics6040663","volume":"6","author":"M Gujjar","year":"2014","unstructured":"Gujjar M, Banga AK. Iontophoretic and microneedle mediated transdermal delivery of glycopyrrolate. Pharmaceutics. 2014;6(4):663\u201371.","journal-title":"Pharmaceutics."},{"issue":"6","key":"544_CR76","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10856-017-5899-2","volume":"28","author":"S Tambunlertchai","year":"2017","unstructured":"Tambunlertchai S, Srisang S, Nasongkla N. Development of antimicrobial coating by later-by-layer dip coating of chlorhexidine-loaded micelles. J Mater Sci Mater Med. 2017;28(6):90.","journal-title":"J Mater Sci Mater Med"},{"issue":"2\u20133","key":"544_CR77","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0168-3659(01)00294-2","volume":"73","author":"KA Janes","year":"2001","unstructured":"Janes KA, Fresneau MP, Marazuela A, Fabra A. Alonso MaJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001;73(2\u20133):255\u201367.","journal-title":"J Control Release"},{"issue":"6","key":"544_CR78","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1523-1747.1999.00774.x","volume":"113","author":"MJ Spears","year":"1999","unstructured":"Spears MJ, McKillop K, Marshall JL, Stone KJ, Lilly NA, Warner RR, et al. Water disrupts stratum corneum lipid lamellae: damage is similar to surfactants1. J Investig Dermatol. 1999;113(6):960\u20136.","journal-title":"J Investig Dermatol"},{"key":"544_CR79","first-page":"24","volume-title":"Occlusion does not uniformly enhance penetration in vivo","author":"HI Maibach","year":"2002","unstructured":"Maibach HI, Bucks DA. Occlusion does not uniformly enhance penetration in vivo. Topical Absorption of Dermatological Products: CRC Press; 2002. p. 24\u201346."},{"issue":"3","key":"544_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0169-409X(95)00019-4","volume":"18","author":"M-H Schmid","year":"1996","unstructured":"Schmid M-H, Korting H. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev. 1996;18(3):335\u201342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"544_CR81","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1166\/jbn.2015.2139","volume":"11","author":"LA Huber","year":"2015","unstructured":"Huber LA, Pereira TA, Ramos DN, Rezende LC, Emery FS, Sobral LM, et al. Topical skin cancer therapy using doxorubicin-loaded cationic lipid nanoparticles and iontophoresis. J Biomed Nanotechnol. 2015;11(11):1975\u201388.","journal-title":"J Biomed Nanotechnol"},{"issue":"9","key":"544_CR82","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/17425247.2016.1193152","volume":"13","author":"NR Khan","year":"2016","unstructured":"Khan NR, Wong TW. Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes. Expert Opin Drug Deliv. 2016;13(9):1209\u201319.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"544_CR83","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/jid.1965.126","volume":"45","author":"GD Weinstein","year":"1965","unstructured":"Weinstein GD, Van Scott EJ. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol. 1965;45(4):257\u201362.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"544_CR84","doi-asserted-by":"publisher","first-page":"051006","DOI":"10.1117\/1.JBO.20.5.051006","volume":"20","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Choe C-S, Ahlberg S, Meinke MC, Ulrike A, Lademann JM, et al. Penetration of silver nanoparticles into porcine skin ex vivo using fluorescence lifetime imaging microscopy, Raman microscopy, and surface-enhanced Raman scattering microscopy. J Biomed Opt. 2014;20(5):051006.","journal-title":"J Biomed Opt"},{"issue":"6","key":"544_CR85","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.biomaterials.2011.10.085","volume":"33","author":"Y Yu","year":"2012","unstructured":"Yu Y, Wang Z-H, Zhang L, Yao H-J, Zhang Y, Li R-J, et al. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma. Biomaterials. 2012;33(6):1808\u201320.","journal-title":"Biomaterials."},{"issue":"939","key":"544_CR86","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1259\/bjr\/13169882","volume":"79","author":"J Hainfeld","year":"2006","unstructured":"Hainfeld J, Slatkin D, Focella T, Smilowitz H. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79(939):248\u201353.","journal-title":"Br J Radiol"},{"issue":"10","key":"544_CR87","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s11051-017-4036-y","volume":"19","author":"P-H Lu","year":"2017","unstructured":"Lu P-H, Li H-J, Chang H-H, Wu N-L, Hung C-F. Gold nanoparticles induce cell death and suppress migration of melanoma cells. J Nanopart Res. 2017;19(10):342.","journal-title":"J Nanopart Res"},{"issue":"11","key":"544_CR88","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.addr.2008.03.013","volume":"60","author":"R Bhattacharya","year":"2008","unstructured":"Bhattacharya R, Mukherjee P. Biological properties of \u201cnaked\u201d metal nanoparticles. Adv Drug Deliv Rev. 2008;60(11):1289\u2013306.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"544_CR89","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1021\/mp5007163","volume":"12","author":"S Labala","year":"2015","unstructured":"Labala S, Mandapalli PK, Kurumaddali A, Venuganti VVK. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma. Mol Pharm. 2015;12(3):878\u201388.","journal-title":"Mol Pharm"},{"issue":"2\u20133","key":"544_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0168-3659(01)00290-5","volume":"73","author":"K Moser","year":"2001","unstructured":"Moser K, Kriwet K, Kalia YN, Guy RH. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J Control Release. 2001;73(2\u20133):245\u201353.","journal-title":"J Control Release"},{"key":"544_CR91","first-page":"85","volume":"11","author":"T Higuchi","year":"1960","unstructured":"Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem. 1960;11:85\u201397.","journal-title":"J Soc Cosmet Chem"},{"issue":"2","key":"544_CR92","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000063904","volume":"205","author":"AB Bong","year":"2002","unstructured":"Bong AB, Bonnekoh B, Franke I, Sch\u00f6n MP, Ulrich J, Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology. 2002;205(2):135\u20138.","journal-title":"Dermatology."},{"issue":"4","key":"544_CR93","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1365-2133.2004.06176.x","volume":"151","author":"P Michalopoulos","year":"2004","unstructured":"Michalopoulos P, Yawalkar N, Br\u00f6nnimann M, Kappeler A, Braathen L. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. Br J Dermatol. 2004;151(4):903\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"544_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archderm.139.3.273","volume":"139","author":"IH Wolf","year":"2003","unstructured":"Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol. 2003;139(3):273\u20136.","journal-title":"Arch Dermatol"},{"issue":"4","key":"544_CR95","first-page":"510","volume":"141","author":"IH Wolf","year":"2005","unstructured":"Wolf IH, Cerroni L, Kodama K, Kerl H. Treatment of Lentigo Maligna (melanoma in situ) with the immune response modifier imiquimod. JAMA Dermatology. 2005;141(4):510\u20134.","journal-title":"JAMA Dermatology"},{"issue":"4","key":"544_CR96","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/jdv.14085","volume":"31","author":"D Tio","year":"2017","unstructured":"Tio D, Van der Woude J, Prinsen C, Jansma E, Hoekzema R, Van Montfrans C. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures. J Eur Acad Dermatol Venereol. 2017;31(4):616\u201324.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"544_CR97","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00262-016-1880-z","volume":"65","author":"IS Mauldin","year":"2016","unstructured":"Mauldin IS, Wages NA, Stowman AM, Wang E, Olson WC, Deacon DH, et al. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. Cancer Immunol Immunother. 2016;65(10):1201\u201312.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"544_CR98","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","volume":"65","author":"CK Bichakjian","year":"2011","unstructured":"Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik JM, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011;65(5):1032\u201347.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"544_CR99","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/jid.2014.194","volume":"134","author":"C Aspord","year":"2014","unstructured":"Aspord C, Tramcourt L, Leloup C, Molens J-P, Leccia M-T, Charles J, et al. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization. J Investig Dermatol. 2014;134(10):2551\u201361.","journal-title":"J Investig Dermatol"},{"issue":"5","key":"544_CR100","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaad.2003.11.057","volume":"50","author":"A-M Powell","year":"2004","unstructured":"Powell A-M, Russell-Jones R. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy. J Am Acad Dermatol. 2004;50(5):792\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"544_CR101","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-2133.2006.07514.x","volume":"155","author":"MF Naylor","year":"2006","unstructured":"Naylor MF, Chen WR, Teague TK, Perry L, Nordquist RE. In situ photoimmunotherapy: a tumour-directed treatment for melanoma. Br J Dermatol. 2006;155(6):1287\u201392.","journal-title":"Br J Dermatol"},{"issue":"1","key":"544_CR102","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1593\/neo.07885","volume":"10","author":"EG Rodrigues","year":"2008","unstructured":"Rodrigues EG, Dobroff AS, Cavarsan CF, Paschoalin T, Nimrichter L, Mortara RA, et al. Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin. Neoplasia (New York, NY). 2008;10(1):61.","journal-title":"Neoplasia (New York, NY)"},{"issue":"43","key":"544_CR103","doi-asserted-by":"publisher","first-page":"33464","DOI":"10.1074\/jbc.M001491200","volume":"275","author":"PI Silva","year":"2000","unstructured":"Silva PI, Daffre S, Bulet P. Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem. 2000;275(43):33464\u201370.","journal-title":"J Biol Chem"},{"issue":"4","key":"544_CR104","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.0022-202X.2004.22413.x","volume":"122","author":"BM Magnusson","year":"2004","unstructured":"Magnusson BM, Anissimov YG, Cross SE, Roberts MS. Molecular size as the main determinant of solute maximum flux across the skin. J Investig Dermatol. 2004;122(4):993\u20139.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"544_CR105","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17425247.2017.1260119","volume":"14","author":"E Wenande","year":"2017","unstructured":"Wenande E, Olesen UH, Nielsen MMB, Janfelt C, Hansen SH, Anderson RR, et al. Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake. Expert Opinion Drug Deliv. 2017;14(3):307\u201317.","journal-title":"Expert Opinion Drug Deliv"},{"issue":"6","key":"544_CR106","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/sj.jid.5700807","volume":"127","author":"JE Gudjonsson","year":"2007","unstructured":"Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT. Mouse models of psoriasis. J Investig Dermatol. 2007;127(6):1292\u2013308.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"544_CR107","doi-asserted-by":"publisher","first-page":"15885","DOI":"10.1038\/s41598-017-15830-7","volume":"7","author":"JCJ Wei","year":"2017","unstructured":"Wei JCJ, Edwards GA, Martin DJ, Huang H, Crichton ML, Kendall MAF. Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micro-medical device translation: from mice, rats, rabbits, pigs to humans. Sci Rep. 2017;7(1):15885.","journal-title":"Sci Rep"},{"issue":"2","key":"544_CR108","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","volume":"66","author":"J Lademann","year":"2007","unstructured":"Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles\u2014an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159\u201364.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"544_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31693-y","volume":"8","author":"MF Peralta","year":"2018","unstructured":"Peralta MF, Guzm\u00e1n ML, P\u00e9rez A, Apezteguia GA, F\u00f3rmica ML, Romero EL, et al. Liposomes can both enhance or reduce drugs penetration through the skin. Sci Rep. 2018;8(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"11","key":"544_CR110","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1002\/jps.23282","volume":"101","author":"MM Abdel-Mottaleb","year":"2012","unstructured":"Abdel-Mottaleb MM, Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Surface-charge-dependent nanoparticles accumulation in inflamed skin. J Pharm Sci. 2012;101(11):4231\u20139.","journal-title":"J Pharm Sci"},{"issue":"6","key":"544_CR111","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaad.2015.02.008","volume":"72","author":"SM Swetter","year":"2015","unstructured":"Swetter SM, Chen FW, Kim DD, Egbert BM. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. J Am Acad Dermatol. 2015;72(6):1047\u201353.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"544_CR112","first-page":"107","volume":"12","author":"SD Moon","year":"2013","unstructured":"Moon SD, Spencer JM. Clearance of invasive melanoma with topical imiquimod. J Drugs Dermatol. 2013;12(1):107\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"42","key":"544_CR113","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1016\/j.vaccine.2009.07.062","volume":"27","author":"BA Chang","year":"2009","unstructured":"Chang BA, Cross JL, Najar HM, Dutz JP. Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine. 2009;27(42):5791\u20139.","journal-title":"Vaccine."},{"issue":"3","key":"544_CR114","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2326-6066.CIR-14-0202","volume":"3","author":"RL Sabado","year":"2015","unstructured":"Sabado RL, Pavlick A, Gnjatic S, Cruz CM, Vengco I, Hasan F, et al. Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma. Cancer Immunol Res. 2015;3(3):278\u201387.","journal-title":"Cancer Immunol Res"},{"key":"544_CR115","doi-asserted-by":"crossref","unstructured":"Royal RE, Vence LM, Wray T, Cormier JN, Lee JE, Gershenwald JE, et al. A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application. Proc Am Soc Clin Oncol; 2017.","DOI":"10.1200\/JCO.2017.35.15_suppl.9582"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-020-00544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-020-00544-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-020-00544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:04:30Z","timestamp":1674824670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-020-00544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1208\/s12248-020-00544-y","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}